Oncology Medical Director
Company Overview
Accent Therapeutics is a biopharmaceutical company based in Lexington, MA that is focused on developing first in class and best in class small molecule Inhibitors of RNA modifying enzymes (RMEs) and adjacent pathways to primarily treat cancer. Founded in 2017, named as one of Fortune’s Top Ten Workplaces in Healthcare and Biopharma in 2020, and one of Fierce Biotech’s Fierce15 in 2020, Accent is building a highly collaborative team of experienced high-caliber drug developers to develop life-changing therapies for patients.
Position Summary
The Medical Director will report to the Chief Medical Officer and will be the lead physician for the IND approved oncology clinical programs for Accent’s first and second small molecule drug candidates. The Medical Director will be responsible for medical monitoring of all clinical programs for these assets including delivery of proof of concept data. In addition, the Medical Director will contribute to ongoing strategic development of the clinical programs and pipeline compounds, including clinical presentations and publications as well as key opinion leader relationships for the clinical programs.
Responsibilities
- Provide oncology clinical expertise and leadership to our clinical development program (preclinical and clinical) teams
- Manage studies regarding clinical issues, safety monitoring, and integration of translational scientific data (PK, PD, pre-clinical) into clinical decisions
- Lead interactions with investigators/physicians and clinical advisors
- Design and draft clinical documents in concert with translational biology, statistician, clinical operations, and regulatory
- Provide strategic guidance for evolving clinical development strategies (e.g. monotherapy indication expansion and combinations), assessment of competition, and approval strategy
- Review literature and author clinical abstracts, presentations for clinical conferences
- Provide medical and scientific expertise to preclinical discovery groups for pipeline compounds in preclinical development
Requirements
- MD with expertise in oncology
- Board eligibility or certification preferred but not required.
- 3+ years of early-stage oncology drug development experience in a pharmaceutical or therapeutic biotechnology company
- Industry experience in clinical trial conduct and safety reporting
- Experience leading multidisciplinary cross-functional teams and direct management experience is highly desirable
- Strong communication skills to facilitate exchanges within clinical group and with scientists, guiding transition of compounds form preclinical stage to first-in-human studies and beyond
- Excellent interpersonal and presentation skills
- Willing to travel occasionally, meet with investigators, attend conferences, participate in advisory boards (mostly domestic and sometimes on weekends)
Accent Therapeutics provides equal employment opportunities to all employees and applicants for employment and prohibits discrimination and harassment of any type without regard to race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, sexual orientation, gender identity or expression, or any other characteristic protected by federal, state, or local laws.
This policy applies to all terms and conditions of employment, including recruiting, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absences, compensation, and training.